Security key
77313F106
ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT)
CUSIP: 77313F106
Q1 2026 13F Holders as of 31 Mar 2026
- Total 13F shares
- 97,171,775
- Share change
- +5,282,410
- Total reported value
- $347,759,663
- Put/Call ratio
- 44%
- Reported price per share
- $3.58
- Number of holders
- 194
- Value change
- +$19,692,779
- Number of buys
- 118
- Number of sells
- 83
- Security type / class
- Equity / Common Stock
- Shares outstanding
- 109,265,652
Holder snapshot
9 facts
Security identity
2 facts
Report period
Q1 2026
Institutions
194
Top holders
10
RCKT full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
ROCKET PHARMACEUTICALS, INC. SEC filings
ROCKET PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 77313F106
Recent filing periods:
Ownership snapshot
Top reported holders of RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
MAVERICK CAPITAL LTD
13D/G signal
MAVERICK CAPITAL LTD
Evidence rows
15
Latest as of
02 Jan 2026
13D/G
13F
3/4/5
Lead comparable stake: 2.3%
13D/G row: MAVERICK CAPITAL LTD
Showing 1-6 of 15 holder rows.
Rank 1 holder
MAVERICK CAPITAL LTD
13D/G
13F
- Ownership
- 2.3%
- Position
- $9.55M
Rank 2 holder
WELLINGTON MANAGEMENT GROUP LLP
13D/G
- Ownership
- 0.9%
- Position
- $7.9M
Rank 3 holder
Roderick Wong
3/4/5
- Ownership
- 17%
- Position
- $44.69M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MAVERICK CAPITAL LTD |
13D/G
13F
Company
|
2.3%
|
$9,549,818
2,513,110 shares
|
-$22,232,671 | 31 Dec 2025 |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
|
0.9%
|
$7,895,181
1,004,476 shares
|
-$48,317,346 | 30 May 2025 |
| Roderick Wong |
3/4/5
Director, 10%+ Owner
|
17%
|
$44,689,444
18,236,124 shares
|
— | 18 Jun 2025 |
| David P. Southwell |
3/4/5
Director
|
0.13%
|
$354,806
144,784 shares
|
— | 18 Jun 2025 |
| Pedro P. Granadillo |
3/4/5
Director
|
0.05%
|
$134,131
54,734 shares
|
— | 18 Jun 2025 |
| Peter Fong |
3/4/5
Director
|
0.05%
|
$174,932
53,333 shares
|
— | 24 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
194
Shares
97,171,775
Rows available
194
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
183
Q1 2026 holders
194
Holder diff
11
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend